Autopsy report · NCT00116571
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
Cause of deathNo reason given
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 180 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- QLT Inc.
- Sponsor type
- Industry
- Conditions
- Prostatic Hyperplasia
- Interventions
- Lemuteporfin for injection; Transurethral drug delivery system; Transurethral light delivery system
- Participants
- 180
- Sites
- 9
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.